Streptomycins and their Derivatives; Salts Thereof
Código 294120 (Harmonized System 2012 by 6 digits)
2012: US$43.7k, International Sales
2023: US$2.96M, International Purchases
Código 294120 (Harmonized System 2012 by 6 digits)
2012: US$43.7k, International Sales
2023: US$2.96M, International Purchases
In 2012, the states with the most international sales in Streptomycins and their Derivatives; Salts Thereof were Ciudad de México (US$43.7k).
The states with the most international purchases in 2023 were Estado de México (US$1.89M), Jalisco (US$779k), and Ciudad de México (US$268k).
In 2012, the main commercial destinations of Streptomycins and their Derivatives; Salts Thereof were Vietnam (US$43.5k), Spain (US$108), Guatemala (US$20), Panama (US$20), and El Salvador (US$20).
The main commercial origins of Streptomycins and their Derivatives; Salts Thereof in 2023 were China (US$2.93M), United States (US$3.13k), Israel (US$1.3k), and Switzerland (US$77).
In the global context, the main exporting countries of Streptomycins and their Derivatives; Salts Thereof in 2022 were China (US$47.5M), United States (US$5.21M), and Netherlands (US$4.79M). In the same year, the main importing countries of Streptomycins and their Derivatives; Salts Thereof were India (US$7.27M), Netherlands (US$7.24M), and United States (US$3.89M).
The visualizations show the net balance of Streptomycins and their Derivatives; Salts Thereof at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024: US$290k, International Purchases
In November 2024, international sales of Streptomycins and their Derivatives; Salts Thereof were US$0, while international purchases reached US$290k. The above results in a trade balance of -US$290k.
Ciudad de México: US$43.7k, State with the Most International Sales (2012)
Vietnam: US$43.5k, Main commercial destination (2012)
In 2012, the states with the highest international sales in Streptomycins and their Derivatives; Salts Thereof were Ciudad de México (US$43.7k).
In 2012, the countries with the most international purchases from Mexico were Vietnam (US$43.5k), Spain (US$108), Guatemala (US$20), Panama (US$20), and El Salvador (US$20).
Estado de México: US$1.89M, State with the Most International Purchases (2023)
China: US$2.93M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Streptomycins and their Derivatives; Salts Thereof were Estado de México (US$1.89M), Jalisco (US$779k), and Ciudad de México (US$268k).
The countries with the most international sales to Mexico in 2023 were China (US$2.93M), United States (US$3.13k), Israel (US$1.3k), and Switzerland (US$77).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Streptomycins and their Derivatives; Salts Thereof and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Streptomycins and their Derivatives; Salts Thereof. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Streptomycins and their Derivatives; Salts Thereof. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Streptomycins and their Derivatives; Salts Thereof were China (US$47.5M), United States (US$5.21M), and Netherlands (US$4.79M). In the same year, the main importing countries for Streptomycins and their Derivatives; Salts Thereof were India (US$7.27M), Netherlands (US$7.24M), and United States (US$3.89M).